Skip to main content
. Author manuscript; available in PMC: 2019 Jan 4.
Published in final edited form as: JCO Precis Oncol. 2017 Aug 4;2017:10.1200/PO.17.00071. doi: 10.1200/PO.17.00071

Table A2.

Histologic Subtypes

High Grade Establishment Rate Among High Grade Time to Establishment (days)
Subtype No. No. % High Grade No. % (success/high grade) Median Range
Angiomyoplipoma 1 0 0.0
Angiosarcoma 1 1 100.0 0 0.0
Chondrosarcoma 1 0 0.0
Chordoma 1 0 0.0
Dermatofibrosarcoma protuberans 1 1 100.0 0 0.0
Desmoid tumor 1 0 0.0
Desmoplastic small round cell tumor 2 100.0 0 0.0
Embryonal sarcoma 1 1 100.0 0 0.0
Epithelioid sarcoma 3 3 100.0 0 0.0
Ewing sarcoma, extraosseous 3 3 100.0 1 33.3 49 49
Fibromyxoid sarcoma 2 1 50.0 0 0.0
Follicular dendritic cell sarcoma 2 2 100.0 1 50.0 23 23
GI stromal tumor 7 4 57.1 1 25.0 84 84
Intramuscular angioma 1 0 0.0
Leiomyoma 3 0 0.0
Leiomyosarcoma 15 15 100.0 8 53.3 86 29–170
Liposarcoma 27 12 44.4 8 66.7 80 9–184
Malignant peripheral nerve sheath tumor 1 0 0.0
Myxofibrosarcoma 5 5 100.0 3 60.0 70 14–121
Myxoma 3 0 0.0
NOS/spindle cell/UPS 16 15 93.8 7 46.7 30 16–142
Osteosarcoma, extraosseous 1 1 100.0 1 100.0 27 27
Phyllodes tumor 1 1 100.0 0 0.0
Radiation-associated sarcoma 1 1 100.0 0 0.0
Rhabdomyosarcoma 1 1 100.0 1 100.0 44 44
Schwannoma 1 0 0.0
Solitary fibrous tumor 3 0 0.0
Synovial sarcoma 2 2 100.0 1 50.0 91 91

Abbreviations: NOS, not otherwise specified; UPS, undifferentiated pleomorphic sarcoma.